BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16869776)

  • 1. Is oncogene addiction angiogenesis-dependent?
    Folkman J; Ryeom S
    Cold Spring Harb Symp Quant Biol; 2005; 70():389-97. PubMed ID: 16869776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?
    Felsher DW
    Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor dormancy and oncogene addiction.
    Felsher DW
    APMIS; 2008; 116(7-8):629-37. PubMed ID: 18834407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role for oncogenic Ras in tumour maintenance.
    Chin L; Tam A; Pomerantz J; Wong M; Holash J; Bardeesy N; Shen Q; O'Hagan R; Pantginis J; Zhou H; Horner JW; Cordon-Cardo C; Yancopoulos GD; DePinho RA
    Nature; 1999 Jul; 400(6743):468-72. PubMed ID: 10440378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis. Successful growth of tumours.
    Ross R
    Nature; 1989 May; 339(6219):16-7. PubMed ID: 2469961
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained loss of a neoplastic phenotype by brief inactivation of MYC.
    Jain M; Arvanitis C; Chu K; Dewey W; Leonhardt E; Trinh M; Sundberg CD; Bishop JM; Felsher DW
    Science; 2002 Jul; 297(5578):102-4. PubMed ID: 12098700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells.
    Hyder SM; Liang Y; Wu J; Welbern V
    Endocr Relat Cancer; 2009 Sep; 16(3):809-17. PubMed ID: 19570906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic enzymes regulated by the Myc oncogene are possible targets for chemotherapy or chemoprevention.
    Rimpi S; Nilsson JA
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):305-10. PubMed ID: 17371266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene addiction: sometimes a temporary slavery.
    Jonkers J; Berns A
    Cancer Cell; 2004 Dec; 6(6):535-8. PubMed ID: 15607957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extremely weak tumor-promoting effect of troglitazone on splenic hemangiosarcomas in rasH2 mice induced by urethane.
    Jin M; Matsumoto S; Dewa Y; Nishimura J; Saekusa Y; Hasumi K; Mitsumori K
    Arch Toxicol; 2008 Oct; 82(10):771-7. PubMed ID: 18465119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
    Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
    Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis.
    Bergers G; Hanahan D; Coussens LM
    Int J Dev Biol; 1998; 42(7):995-1002. PubMed ID: 9853830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rehabilitation of cancer through oncogene inactivation.
    Shachaf CM; Felsher DW
    Trends Mol Med; 2005 Jul; 11(7):316-21. PubMed ID: 15955741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K; Baudino TA
    Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF-8b induces growth and rich vascularization in an orthotopic PC-3 model of prostate cancer.
    Valta MP; Tuomela J; Vuorikoski H; Loponen N; Väänänen RM; Pettersson K; Väänänen HK; Härkönen PL
    J Cell Biochem; 2009 Jul; 107(4):769-84. PubMed ID: 19415685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and cancer: the oncogene-driven connection.
    Borrello MG; Degl'Innocenti D; Pierotti MA
    Cancer Lett; 2008 Aug; 267(2):262-70. PubMed ID: 18502035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors.
    Soucek L; Lawlor ER; Soto D; Shchors K; Swigart LB; Evan GI
    Nat Med; 2007 Oct; 13(10):1211-8. PubMed ID: 17906636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.